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Previous data suggest women are at increased risk of death from
aortic dissection. Therefore, we analyzed data from the GenTAC
registry, the NIH-sponsored program that collects information
about individuals with genetically triggered thoracic aortic
aneurysms and cardiovascular conditions. We performed cross-
sectional analyses in adults with Marfan syndrome (MFS), fam-
ilial thoracic aortic aneurysm or dissection (FTAAD), bicuspid
aortic valve (BAV) with thoracic aortic aneurysm or dissection,
and subjects under 50 years of age with thoracic aortic aneurysm
or dissection (TAAD <50 years). Women comprised 32% of
1,449 subjects and were 21% of subjects with BAV, 34% with
FTAAD, 22% with TAAD<50 years, and 47% with MFS. Thora-
cic aortic dissections occurred with equal gender frequency yet
womenwithBAVhadmore extensive dissections. Aortic sizewas
smaller in women but was similar after controlling for BSA. Age
at operation for aortic valve dysfunction, aneurysmor dissection
did not differ by gender.Multivariate analysis (adjusting for age,
BSA,hypertension, study site, diabetes, and subgroupdiagnoses)
showed that women had fewer total aortic surgeries (OR¼ 0.65,
P< 0.01) and were less likely to receive angiotensin converting
enzyme inhibitors (ACEi; OR¼ 0.68, P< 0.05). As in BAV, other
genetically triggered aortic diseases such as FTAAD and TAAD
<50aremore commoninmales. Inwomen,decreasedprevalence
of aortic operations and less treatment with ACEi may be due to
their smaller absolute aortic diameters. Longitudinal studies are
needed to determine if women are at higher risk for adverse
events.  2013 Wiley Periodicals, Inc.
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INTRODUCTION
Women with cardiovascular disease face unique risks and out-
comes when compared to men. For example, despite a lower
incidence of coronary artery disease in young women versus
young men, the clinical outcome of acute myocardial infarction
among young females is worse [Vaccarino et al., 1999]. The
International Registry of Acute Aortic Dissections (IRAD) iden-
tified significant gender-related differences in individuals with
aortic dissection [Nienaber et al., 2004]. That study found that
women aremore likely to die following an acute dissection and to
suffer more aorta-related complications than men. Davies et al.
[2006] have suggested that female gender is an independent risk
factor for adverse aortic events including dissection and rupture
and death. In Marfan syndrome (MFS), early surgical replace-
ment of the sinus of Valsalva has dramatically increased life
expectancy [Silverman et al., 1995], yet whether women with
MFS-related aortic disease are treated differently than men is not
well studied. Furthermore, gender differences in other genetically
triggered or idiopathic aortic diseases including bicuspid
aortic valve (BAV), familial thoracic aortic aneurysm and
dissection (FTAAD) or individuals under 50 years of age with
thoracic aortic aneurysm or dissection (TAAD <50) have
received little attention.
The national registry of Genetically Triggered Thoracic Aortic
Aneurysms and Cardiovascular Conditions (GenTAC) is a rich
source of clinical data on individuals with known or presumed
genetic conditions associated with aortic aneurysm and dissection
[Eagle and GenTACConsortium, 2009; Kroner et al., 2011]. In this
studywe sought to determine if therewere gender-baseddifferences
in the prevalence of aortic disease, its severity, and its treatment in
the GenTAC cohort.
MATERIALS AND METHODS
The design and methods for the GenTAC Registry are described
elsewhere [Eagle and GenTAC Consortium, 2009]. Each of the five
GenTACPhase I sites obtained approval to conduct this study from
their respective institutional review boards. Informed consent was
obtained at the sites of enrollment.
Study Population
From November 1, 2007 to December 31, 2010, a total of 1,449
adults with the conditions under study were enrolled into GenTAC
(including 458 withMFS, 495 with BAV, 219 with FTAAD, and 277
with TAAD<50 years) who comprise the population of this cross-
sectional study [Kroner et al., 2011]. Subjects with Loeys–Dietz
syndrome, Turner syndrome, Ehlers–Danlos syndrome, and
Shprintzen–Goldberg syndromewere excludeddue to small sample
sizes. Description of dissection was based on the DeBakey classi-
fication [DeBakey et al., 1965] where type I includes the ascending
aorta, aortic arch, and descending aorta, type II is confined to the
ascending aorta, and type III is confined to the descending aorta.
Dissections limited to the abdominal aortawere counted separately.
Total aortic operations included the following: aortic valve repair,
isolated aortic valve replacement, valve-replacing aortic root
replacement, valve-sparring aortic root replacement, ascending
aortic replacement, aortic arch replacement, coarctation repair,
descending thoracic aortic replacement, and thoracoabdominal
aortic replacement. On a subset of surgical patients, operative
complications, age of first operation and, total number of oper-
ations were reviewed. Operative complications included: myocar-
dial infarction, stroke, paraplegia/paralysis, prolonged intubation,
acute renal failure, bleeding requiring operation, and vocal cord
paralysis.
Echocardiographic Measurements
Reports of the most recent transthoracic echocardiogram were
transmitted from GenTAC study sites at the time of enrollment
and were entered into a database. Only data from subjects with
native aortas were considered. The aortic annulus, sinuses of
Valsalva (root), and ascending aorta were compared using absolute
measurements. In order to account for differences in body size,
values were indexed both as Z-scores and as observed/expected
ratios. These valuesweredetermined fromestablished formulas and
include adjustments for age and body surface area (BSA) [Roman
et al., 1989]. Aortic regurgitation and stenosis were evaluated by
clinical report as absent, mild, moderate, or severe.
Statistical Analysis
Data are described by means with standard deviations and fre-
quencies with percentages. To investigate gender differences in
TABLE I. Primary Diagnosis by Gender, n (%)
Primary diagnosis Male (n¼ 992) Female (n¼ 457) Total (n¼ 1,449) P-value (Chisq)
MFS 241 (52.6) 217 (47.4) 458 0.262
BAV with TAAD 390 (79) 105 (21) 495 <0.0001
FTAAD 144 (65.8) 75(34.3) 219 <0.0001
TAAD <50 217 (78.3) 60 (21.7) 277 <0.0001
Chisq, chi squared analyses; MFS, Marfan syndrome; BAV with TAAD, bicuspid aortic valve with thoracic aortic aneurysm or dissection; FTAAD, familial thoracic aortic aneurysm/dissection;
TAAD <50, other thoracic aortic aneurysm/dissection <50 years.



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































HOLMES ET AL. 781
demographic data and outcome measurements, bivariate chi-
squared, and t-tests for categorical and continuous variables,
respectively, were used. Gender differences in demographics, gen-
eral health, prescribed medications, surgical history, past dissec-
tions, and imaging data were examined by specific sub-group
diagnoses and across the GenTAC study population. In order to
account for multiple testing, and minimize the potential of falsely
concluding a significant difference, the Holm–Bonferroni posthoc
test [Holm, 1979] was used for gender comparisons involving the
total population. A multivariate logistic regression model, with
gender as the outcome, was built to further analyze the gender
comparisons by controlling for possible multicollinearity between
each individual covariate’s relationship with gender. All demo-
graphic, general health and drug history covariateswere included in
the logistic regression (except surgical, dissection and imaging data,
which were excluded due to relatively low sample sizes), and odds
ratios were calculated along with their 95% confidence intervals for
each covariate. The model also controlled for history of hyper-
tension, BSA, age at diagnosis, diabetes, study site, and primary




Women comprised 457 (32%) of the total subjects (Table I). All
groups had a statistically significantmale predominance, except for
MFS, where 217 of 458 (47%) were women.Women accounted for
105of 495 (21%)withBAV, 75of 219 (34%)with FTAAD, and60of
277 (22%) with TAAD <50 years. There was no significant differ-
ence in age of enrollment by gender overall or within the diagnostic
groups. Therewere also no gender differences among the diagnostic
groups for race, ethnicity, or family history of disease. There was no
gender difference in baseline coronary disease risk factors such as
hypertension or diabetes (Table II). Although not statistically
significant, men with BAV tended to report more atherosclerotic
disease or myocardial infarction (8.8%) than women (5.1%,
P¼ 0.10).
Over 85% of men and women were on medications for cardi-
ovascular disease (Table II). There was no difference by gender in
overall medication usage; however, in univariate analyses women
were less likely thanmen to takeACEi (19%vs. 30%) orHMG-CoA
reductase inhibitor (statin) cholesterol lowering drugs (20% vs.
30%, both P< 0.003).Within theMFS group, there was no gender-
related difference in the use of beta-blocker or losartan; however,
women withMFS were less likely to receive an ACE inhibitor (13%
vs. 20%, P< 0.05).
Echocardiographic Data
After excluding those that had aortic operations, the diameter of the
aortic annulus, sinuses of Valsalva and ascending aorta were
examined for gender differences (Table III).Women demonstrated
smaller absolute aortic measurements (P< 0.003). However, after
adjusting for body size and age there were no differences in Z-score
values or observed/predicted ratios of the aortic root between
GenTAC men and women. Similarly, there were no gender differ-
ences in degree of aortic valve regurgitation or stenosis.
Aortic Dissection
Within the study population, 303 subjects survived an aortic
dissection. Aortic dissection occurred with equal gender frequency
in the entirepopulation and indiagnostic subgroups. Irrespective of
gender, history of dissection was more common in FTAAD (in 74
subjects, 34%)andTAAD<50 years (88 subjects, 32%) than inMFS
(108 subjects, 23%), or BAV (33 subjects, 7%). Age when a
dissection operation occurred did not differ by gender
(Table IV). Overall there were no gender differences in the percen-
tages of subjects with history of DeBakey I (extending from the
ascending to descending aorta), DeBakey II (confined to the
ascending aorta), or DeBakey type III dissections (confined to
the descending aorta). However, among those with BAV, history
of DeBakey type I dissection was significantly more common in
women than men (5.7% vs. 0.8%, P< 0.005), (Table IV). Further,
ascending aortic dissections were more extensive in women.
TABLE III. Imaging Data by Gender
Statistics Male (n¼ 992) Female (n¼ 457) Total (n¼ 1,449) Adjusted P-value*
Aortic valve annulus n 199 120 319
Native measurement (cm) Mean (std) 2.47 (0.36) 2.28 (0.32) 2.40 (0.36) 0.003
Aortic root n 336 184 520
Native measurement (cm) Mean (std) 4.21 (0.54) 3.83 (0.56) 4.07 (0.57) 0.003
Z-score Mean (std) 3.25 (2.5) 3.08 (3.25) 3.19 (2.79) ns
Indexed value (obs/pred) Mean (std) 1.23 (0.15) 1.21 (0.20) 1.22 (0.17) ns
Ascending aorta n 248 136 384
Native measurement (cm) Mean (std) 3.80 (0.80) 3.42 (0.71) 3.66 (0.79) 0.003
Aortic regurgitation n 223 104 327
Mild n (%) 130 (58.3) 54 (51.9) 184 (56.3) ns
Aortic stenosis n 84 34 118
Mild n (%) 18 (21.4) 7 (20.6) 25 (21.2) ns
*Holm–Bonferroni test. Bold denotes significant values.
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Figure 1 shows that among the small number of survivors of BAV
dissections involving the ascending aorta, 75% extended to the
descending aorta in women, but only 15% extended that far in
men (P< 0.01).
Operations
TableV summarizes the aggregate operative data. Aortic operations
included those on the aortic valve, ascending aorta, descending
aorta, or combination of valve with ascending aortic replacements
and are reported. Overall, fewer women had a history of any aortic
operation (55% vs. 68%, P< 0.001). This difference is largely
demonstrated in the reduced percentage of operations in women
with MFS (49% vs. 74%, P< 0.05), all diagnostic groups demon-
strated a similar trend: BAV (69%vs. 71%), FTAAD(52%vs. 57%),
and TAAD <50 (52% vs. 57%). Examining the operative details,
one exception occurred in women with TAAD <50, where more
women thanmen reported an operation for thoracic aortic replace-
ment (10% vs. 3%). No gender-related differences were detected in
age atfirst operation, numbers of operations or complications (data
not shown).
Multivariate Analysis
The impact of univariate gender differences were examined by
multivariate analysis. The multivariate model included other
potential confounding variables such as site of enrollment, primary
diagnosis, BSA, age at diagnosis, hypertension, and diabetes. The
multivariate logistic regression estimates demonstrate, that overall,
women had fewer aortic operations (OR¼ 0.65, P< 0.01) and less
use of ACEi (OR¼ 0.68, P< 0.05) compared to men (Table VI).
Sensitivity analysis for themodel demonstrated that missing values
















































































































































































































































































































































































































































































































































FIG. 1. Dissection pattern among subjects with BAV. More extensive,
dissections, were significantly more common in women compared
to men (OR¼ 7.82, P< 0.01).
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regression analysis was performed to ensure that gender differences
in ACEi use were not caused by gender differences in aortic
regurgitation, age, left ventricular function, or other drug use.
DISCUSSION
The GenTAC registry recruits individuals with a variety of con-
ditions known to be associatedwith genetic predisposition to aortic
aneurysm and dissection. The overarching goal of the GenTAC
project is to advance knowledge of the genetic triggers of aortic
disease [Eagle and GenTAC Consortium, 2009]. Therefore, our
study explored the effect of gender as a fundamental genetic
difference that runs through the most frequent diagnostic sub-
groups within the GenTAC cohort. With the exception of MFS, we
found male predominance for the primary GenTAC diagnostic
groups. In addition there were important gender differences in
morbidity and medical/operative management. Women were less
likely to undergo aortic surgery and women were less likely to be
treated with ACE inhibitors.
The IRAD gender study provided worrisome data that women
are at significantly higher risk for death after operation for dis-
section (OR 1.4, P< 0.04). Unfortunately the GenTAC and IRAD
data are not directly comparable in this regardbecause of significant
differences in ascertainment between the two studies. IRAD is a
longitudinal study that recruits individuals who have specifically
suffered an acute aortic dissection and reports their outcome
[Hagan et al., 2000]. GenTAC enrolls only living subjects
and recruits either unoperated individuals or survivors of dissec-
tion or other aortic operations [Eagle and GenTAC Consortium,
2009]. Only after longitudinal study of the GenTAC cohort will
we be able to determine if female gender is a significant risk
factor for death following thoracic aortic dissection as the IRAD
study suggests.
The male predominance in BAV aortopathy is already well
established [Roberts, 1970]. The present study supports and
extends these observations by demonstrating amale predominance
in two other diseases of the aorta, FTAAD and TAAD <50 years.
TABLE VI. Associations With Female Versus Male Gender in
Logistic Regression Analysesa (n¼ 1,296)




ACE inhibitor 0.68 (0.47, 0.99) 0.0452
HMG-CoA reductase 0.83 (0.56, 1.23) 0.3749
Losartan 1.05 (0.71, 1.56) 0.7808
Calcium channel
blocker
0.90 (0.56, 1.43) 0.6535
History of operation 0.65 (0.48, 0.88) 0.0065
aCovariates of interest are those with a bivariate test P-value of less than 0.05 (see Table II).
Imaging, dissection, and some specific operation information were not included due to
incomplete data. Model additionally controlled for history of hypertension, BSA, age at
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These striking gender differences in aortic diseases call out for novel
hypotheses. Indeed, the possibility that some as yet undefined
characteristic of the X chromosome protects women is suggested
by the fact that women with a deficiency of the X chromosome
(monosomy X or Turner syndrome) have significantly increased
risk for BAV, aortic aneurysm, and aortic dissection compared to
46,XX women [Carlson and Silberbach, 2007]. One hypothesis
would be that there is a requirement for the full complement of a
critical aorta-related product of a gene present in the pseudo-
autosomal region (PAR1) of the second X chromosome. A second
possibility would be that abnormal expression of autosomal genes
associated with left heart obstruction or aortic aneurysm may be
enhanced in the setting of missing or deficient X chromosomal
factors. Alternatively, it is possible that there are missing X-related
factors that increase susceptibility to testosterone during early
developmental stages as suggested by Zhang et al. [2012]. Women
with familial BAV may also lack X-related protective factors as in
Turner syndrome since in our study, women with BAV have more
extensive aortic dissection compared to men (DeBakey I). Studies
of the biology of the X chromosome employing GenTAC DNA/
tissue repositories and analyses of data from the GenTAC imaging
core will permit exploration of some of these intriguing questions.
We believe that the predilection for aortic operations in males,
particularly operations for aortic aneurysm in MFS men, may be
related to their larger absolute aortic dimensions [Schvartzman
et al., 2000; Biaggi et al., 2009]. In fact, we found that after adjusting
aortic dimensions for values predicted for body size the gender
difference disappeared. Therefore, men may benefit by being more
likely to meet surgical criteria based on absolute size. Perhaps
women face higher long-term morbidity risk because of the reluc-
tance tomedically treat or operate on the unindexed aorta.Women
were also less likely to be treated with ACEi compared to men. This
difference was not an effect of age, alternative drug choice, ven-
tricular function, aortic function, or hypertension.However, others
have raised the concern that women being less likely to be treated
withACEi could be harmful in the setting of heart failure [Sheppard
et al., 2005; Lenzen et al., 2008]. Whether treatment of more men
than women with ACEi influences overall outcome in patients
predisposed to aortic dissection requires long-term study of the
GenTAC cohort.
Study Limitations
As a cross-sectional study, our observations represent a snapshot of
the GenTAC cohort at different points within the natural (and
unnatural) history of aortic disease. The analysis is exploratory,
designed to be hypothesis generating rather than supporting.
While men and women had equal access to our recruitment
effort, we cannot exclude the possibility that more men were
recruited or more women declined to participate at the
GenTAC centers. Including study site in the multivariate analysis
should have controlled for regional disparities in recruitment.
Another possibility, suggested by results from IRAD, is that male
predominance may have been enhanced by disproportional
pre-enrollment mortality in women. We will address these
potential limitations in future longitudinal analyses of the
GenTAC population.
CONCLUSIONS
This cross-sectional analysis of a population at high risk for sig-
nificant morbidity and mortality suggest multiple gender-based
differences. In the GenTAC registry, MFS occurs with equal gender
frequency; yet BAV with TAAD, FTAAD and TAAD <50, affect
fewer women. Women are less likely to have aortic operations. We
speculate that fewer aortic operations are performed in women
because of reluctance to operate or treat the smaller unindexed
female aorta. Fewerwomenmaybe treatedwithACEi. Longitudinal
studies of the GenTAC registry will hopefully determine if these
differences place women at undue risk.
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